Safety Profile
Known Safety Concerns
- Cross-reactivity with legume/peanut allergy in rare cases
- Osmotic diarrhoea and flatulence at high amounts
- FDA GRAS -- safe at typical supplement amounts
- Prebiotic benefit at higher doses
Contraindications
- Cross-reactivity with legume/peanut allergy in rare cases
- Osmotic diarrhoea and flatulence at high amounts
Interactions
Information not yet available for this ingredient profile.
Evidence and Scientific Findings
Ingredient Overview
Gum arabic is a natural polysaccharide exudate from Acacia trees used as an emulsifier, binder, and prebiotic fibre. FDA GRAS status. Fermented by gut bacteria producing short-chain fatty acids — prebiotic effect. Cross-reactivity with legume allergies in rare cases. High amounts cause GI distress.
Biological and Chemical Classification
- Scientific Name
- Acacia Senegal / Acacia seyal gum exudate
Mechanism of Action
Information not yet available for this ingredient profile.
Clinical Evidence of Effectiveness
Information not yet available for this ingredient profile.
Pharmacokinetics
Information not yet available for this ingredient profile.
Recommended Dosage
Information not yet available for this ingredient profile.
SETI — Scientific Evidence Transparency Index
Executive Summary — Ingredient Assessment
- 10 studies reviewed
- 0 high-quality studies (meta-analysis or RCT)
- Main clinical benefit observed: Excipient
- Evidence consistency: High consistency across studies (100%)
- Cross-reactivity with legume/peanut allergy in rare cases
- Osmotic diarrhoea and flatulence at high amounts
- FDA GRAS -- safe at typical supplement amounts
- Prebiotic benefit at higher doses
The available scientific evidence for Gum Arabic (Acacia) indicates notable safety signals that warrant caution. Use should be considered carefully and monitored, particularly in sensitive populations or alongside other medications.
Total SETI Score
High risk| Evidence quality | 10/40 |
| Evidence consistency | 20/20 |
| Safety signals | 0/20 |
| Study recency | 10/10 |
| Evidence transparency | 10/10 |
Evidence Summary
- 10 studies reviewed
- 0 high-quality studies (meta-analysis or systematic review)
- 0 studies identified benefits or no safety concern (GREEN)
- 10 studies reported limited or advisory safety evidence (YELLOW)
Evidence Policy
Only peer-reviewed scientific literature indexed in PubMed or comparable databases is included in this evaluation. Commercial websites, blogs, and marketing materials are excluded. All references include direct traceable links to source documents.
Last updated: 25 მარ 2026, 12:59
Evidence Distribution
-
Observational / other LOW evidence YELLOWThe effectiveness of Sumbawa fermented mare's milk powder with gum arabic [Acacia senegal (L.) Willd] microencapsulant as a modified traditional healthy food. ↗Utama AH et al.. The effectiveness of Sumbawa fermented mare's milk powder with gum arabic [Acacia senegal (L.) Willd] microencapsulant as a modified traditional healthy food.. J Adv Vet Anim Res. 2025. PMID:41069721.PMID 41069721 ↗Journal J Adv Vet Anim ResYear 2025Study type Observational / otherEvidence strength LOW evidencePubMed link https://pubmed.ncbi.nlm.nih.gov/41069721/
-
Observational / other LOW evidence YELLOWTherapeutic Potential of Gum Arabic (Acacia senegal) in Chronic Kidney Disease Management: A Narrative Review. ↗Alobaidi S. Therapeutic Potential of Gum Arabic (Acacia senegal) in Chronic Kidney Disease Management: A Narrative Review.. J Clin Med. 2024. PMID:39407837.PMID 39407837 ↗Journal J Clin MedYear 2024Study type Observational / otherEvidence strength LOW evidencePubMed link https://pubmed.ncbi.nlm.nih.gov/39407837/
-
Observational / other LOW evidence YELLOWGum acacia dietary fiber: Significance in immunomodulation, inflammatory diseases, and cancer. ↗Barkeer S et al.. Gum acacia dietary fiber: Significance in immunomodulation, inflammatory diseases, and cancer.. Phytother Res. 2024. PMID:38272848.PMID 38272848 ↗Journal Phytother ResYear 2024Study type Observational / otherEvidence strength LOW evidencePubMed link https://pubmed.ncbi.nlm.nih.gov/38272848/
-
Observational / other LOW evidence YELLOWEffects of Gum Arabic (Acacia senegal) Powder on Characteristics of Carcass and Breast Meat Quality Parameters in Male Broiler Chickens. ↗Al-Baadani HH et al.. Effects of Gum Arabic (Acacia senegal) Powder on Characteristics of Carcass and Breast Meat Quality Parameters in Male Broiler Chickens.. Foods. 2023. PMID:37444264.PMID 37444264 ↗Journal FoodsYear 2023Study type Observational / otherEvidence strength LOW evidencePubMed link https://pubmed.ncbi.nlm.nih.gov/37444264/
-
Observational / other LOW evidence YELLOWGum Acacia attenuates cisplatin toxic effect spermatogenesis dysfunction and infertility in rats. ↗Nofal AE et al.. Gum Acacia attenuates cisplatin toxic effect spermatogenesis dysfunction and infertility in rats.. Int J Biol Macromol. 2023. PMID:37030465.PMID 37030465 ↗Journal Int J Biol MacromolYear 2023Study type Observational / otherEvidence strength LOW evidencePubMed link https://pubmed.ncbi.nlm.nih.gov/37030465/
-
Observational / other LOW evidence YELLOWEvaluation of gum Arabic (Acacia Senegal) as a natural prebiotic to improve growth performance and health status of broiler chickens. ↗Al-Baadani HH et al.. Evaluation of gum Arabic (Acacia Senegal) as a natural prebiotic to improve growth performance and health status of broiler chickens.. Trop Anim Health Prod. 2022. PMID:35913613.PMID 35913613 ↗Journal Trop Anim Health ProdYear 2022Study type Observational / otherEvidence strength LOW evidencePubMed link https://pubmed.ncbi.nlm.nih.gov/35913613/
-
Observational / other LOW evidence YELLOWThe Effect of Gum Arabic (Acacia Senegal) on Cardiovascular Risk Factors and Gastrointestinal Symptoms in Adults at Risk of Metabolic Syndrome: A… ↗Jarrar AH et al.. The Effect of Gum Arabic (Acacia Senegal) on Cardiovascular Risk Factors and Gastrointestinal Symptoms in Adults at Risk of Metabolic Syndrome: A Randomized Clinical Trial.. Nutrients. 2021. PMID:33435475.PMID 33435475 ↗Journal NutrientsYear 2021Study type Observational / otherEvidence strength LOW evidencePubMed link https://pubmed.ncbi.nlm.nih.gov/33435475/
-
Observational / other LOW evidence YELLOWComparative efficacy of Gum Arabic (Acacia senegal) and Tribulus terrestris on male fertility. ↗Nasir O et al.. Comparative efficacy of Gum Arabic (Acacia senegal) and Tribulus terrestris on male fertility.. Saudi Pharm J. 2020. PMID:33424268.PMID 33424268 ↗Journal Saudi Pharm JYear 2020Study type Observational / otherEvidence strength LOW evidencePubMed link https://pubmed.ncbi.nlm.nih.gov/33424268/
-
Observational / other LOW evidence YELLOWFabrication of a Greener TiO(2)@Gum Arabic-Carbon Paste Electrode for the Electrochemical Detection of Pb(2+) Ions in Plastic Toys. ↗Sivan SK et al.. Fabrication of a Greener TiO(2)@Gum Arabic-Carbon Paste Electrode for the Electrochemical Detection of Pb(2+) Ions in Plastic Toys.. ACS Omega. 2020. PMID:33043219.PMID 33043219 ↗Journal ACS OmegaYear 2020Study type Observational / otherEvidence strength LOW evidencePubMed link https://pubmed.ncbi.nlm.nih.gov/33043219/
-
Observational / other LOW evidence YELLOWA gum Arabic assisted sustainable drug delivery system for adult Drosophila. ↗Liang Q et al.. A gum Arabic assisted sustainable drug delivery system for adult Drosophila.. Biol Open. 2020. PMID:32487516.PMID 32487516 ↗Journal Biol OpenYear 2020Study type Observational / otherEvidence strength LOW evidencePubMed link https://pubmed.ncbi.nlm.nih.gov/32487516/
Score Transparency
0 of 10 approved references (score saturates at 10). More peer-reviewed studies = stronger evidence base.
Method: Q = number of approved references ÷ 10 (capped at 1.0)
Limited — mostly case reports or animal studies
Method: L = mean study-level weight across approved references. Level 1 (meta-analysis / systematic review) = 1.0; Level 2 (RCT) = 0.8; Level 3 (cohort/case-control) = 0.6; Level 4 (case report) = 0.4; Level 5 (animal / in-vitro) = 0.2.
Mixed or neutral — roughly equal benefit and risk signals
Method: D = (sum of risk-scored references − sum of benefit-scored references) ÷ total evidence score, then scaled from [−1, 1] to [0, 1]. 0.0 = pure benefit; 0.5 = neutral; 1.0 = pure risk.
One or more monitoring-level safety signals active
Method: S = 0.5 (neutral baseline) + sum of active signal severity deltas ÷ 10. Severity deltas: Critical = +2.0, High = +1.5, Moderate = +1.0, Low = +0.5. Capped at 1.0.
Final GIRI Score for Gum Arabic (Acacia). Risk level thresholds: Low 0–3.0 · Moderate 3.0–5.5 · High 5.5–7.5 · Critical 7.5–10.
Full methodology & data sources
The GIRI Score is computed entirely from structured data — no editorial scoring or subjective weighting is applied at any step.
- References: Only approved references are counted. Each reference is assigned an evidence level (L1–L5) and a direction (risk / neutral / benefit) by the reference manager or AI classifier.
- Safety Signals: Sourced from regulatory agencies (FDA, EMA, Health Canada, TGA, and others) and pharmacovigilance databases. Only active signals count toward the score.
- Formula version: GIRI Score v3.7.0 — Q × L × D × S × 10.
- Limitations: The score reflects published evidence and recorded signals as of the last update date. It is not a clinical risk assessment and should not replace advice from a qualified healthcare professional.
Risk Level Classification
Based on available regulatory signals and scientific evidence, this ingredient presents a low safety concern under normal conditions of use.
0–3.0
3.0–5.5
5.5–7.5
7.5–10
The score pin shows exactly where this ingredient falls on the fixed risk scale.
What drove the Low classification for Gum Arabic (Acacia)
A score of 2.0 places this ingredient in the Low band. Thresholds: Low 0–3.0 · Moderate 3.0–5.5 · High 5.5–7.5 · Critical 7.5–10.
0 approved references.
Limited — mostly case reports or animal studies (Level 4–5).
Neutral or mixed — benefit and risk signals roughly balanced.
No active signals — S component is at neutral baseline (0.5), contributing no extra risk weight.
No major regulatory restrictions or advisories recorded across monitored jurisdictions (FDA, EMA, Health Canada, TGA, and others).
How are the Low / Moderate / High / Critical thresholds defined?
The four risk levels are fixed score bands. A score is assigned to exactly one level based on where it falls:
| Level | Score | Meaning |
|---|---|---|
| LOW | 0.0 – 2.9 | Sparse or predominantly beneficial evidence. No active safety alerts. |
| MODERATE | 3.0 – 5.4 | Mixed signals — some risk alongside benefit. Caution at high doses or in sensitive groups. |
| HIGH | 5.5 – 7.4 | Multiple studies or regulatory alerts documenting adverse effects. Professional oversight recommended. |
| CRITICAL | 7.5 – 10 | Regulatory restrictions in one or more major jurisdictions. Serious documented harm. Avoid without specialist supervision. |
Thresholds are fixed constants (GIRI_Score_Utils::LEVEL_THRESHOLDS). They do not change per ingredient and are never subject to editorial adjustment.